/
AZN
$171.93-$1.96 (-1.13%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$265.7B
1,551M shares
52-week range
$145.79 – $212.71
39% from low
Exchange
NYSE
CS
Change+$56.58
AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
www.astrazeneca.com- Employees
- 96,100
- IPO / List date
- Oct 23, 2009
Held by traders on TradeandTell
No one on the platform currently holds AZN.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AZN as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.30% ($3.96/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-07 | $0.7950 | 2026-09-08 |
| 2026-02-20 | $1.5950 | 2026-03-23 |
| 2025-08-08 | $0.5150 | 2025-09-08 |
| 2025-02-21 | $1.0500 | 2025-03-24 |
| 2024-08-09 | $0.5000 | 2024-09-09 |
| 2024-02-22 | $0.9850 | 2024-03-25 |
| 2023-08-10 | $0.4650 | 2023-09-11 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-02-02 | 1-for-2reverse |
| 2015-07-27 |
Recent trades on TradeandTell
No one on the platform has traded AZN yet.
